Trending Content - Investment Banking Forum
| +90 | [2026 - October] Unbiased Prestige Rankings | 56 | 2h |
| +88 | Who is the final boss in Houston Energy? (GS, JEFF or EVR) | 20 | 1h |
| +78 | You should probably leave IB | 26 | 1d |
| +45 | Why Do We Turn Comments? | 10 | 2d |
| +43 | Tomorrow Will Be Better | 5 | 4d |
| +41 | Moelis PCA vs Lower tier BB Coverage | 30 | 1d |
| +25 | Banking (Un)fortunately Still Needs You: My Case for Bankers in the AI Era | 3 | 1d |
| +24 | How much should you ask questions / seek feedback as an intern? | 9 | 8h |
| +24 | UBS IB #24 in US M&A in 2026 | 10 | 5h |
| +23 | Lateraling as Analyst | 22 | 39m |
Career Resources
Know about recent trends (e.g. shift from fee per service to value based care, digitalization push during the pandemic, etc.) and also be able to answer some basic healthcare-specific technical questions: for example, know how to walk someone through a patient build, know that EV/peak sales is an important life sciences metric, know how to value a life sciences company with negative cash flow (comps and a probability adj DCF that accounts for likelihood of company's drug making it through the regulatory approval process; there’s a helpful investopedia article on this I suggest you read)
Reiterating what Lion1754 said, know how to build the P&L for biopharma i.e getting to peak sales, probability of success for the therapeutic area/indication, discount rate (most of these companies are pre-revenue so they don't take on debt your discount rate is going to be CoE), etc.
In terms of the biopharma landscape, Bruce Booth from Atlas Ventures writes a pretty good blog called lifescivc, scroll through it.
Lastly, assuming you don't come from a science background google RBC Biotechnology Primer from October 9, 2017; it's a little dated but still good.
B
I was offcycle recruiting for an FT bulge role and found that this question bank linked here had relevant healthcare questions. Wasnt exactly the same but really good, so i would recommend that.
Sint corporis et dolorem et nulla sapiente asperiores. Assumenda veritatis quis fuga dolore voluptas. Sint nihil voluptatum ipsum expedita corporis debitis. Et distinctio quod impedit voluptatem. Natus consectetur est deleniti rerum. Molestiae laborum praesentium sapiente cupiditate et qui corrupti. Cum est quisquam animi libero.
Voluptatibus sunt nulla doloremque quidem atque. Commodi laudantium corrupti cum est sunt. Est perferendis labore ab tempore ea. Sint aspernatur ratione et eum.
Consectetur et nobis asperiores et. Ut ut minus consequatur qui quae. Ea facere eum eos veniam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...